• 2012

Company Description

TransCure bioServices provides predictive, preclinical R&D expertise via its services to the pharmaceutical and biotechnology industry.

TransCure bioServices has developped unique Research & Development (R&D) platforms, called the Humanized Immune System (HIS) and Human Immunodeficiency Virus (HIV) mouse models. They provide access to these platforms as a fee-for-service for the pharmaceutical companies, biotechs as well as academic laboratories which profile new drugs targeting immuno-related diseases and novel anti-HIV/AIDS therapies.